Skip to Content
MilliporeSigma
Search Within
Document Type

222-392-4

Applied Filters:
Keyword:'222-392-4'
Showing 1-27 of 27 results for "222-392-4" within Technical Documents
Spec Sheet: NovAseptic® Valve - NA##/31-222 and NU###/31-222
Sheet Catalogue Number: NA##/31-222 and NU###/31-222 D A Tube Tube B C TC TC E Catalogue No. Structure NA##/31-222 NU###/31-222 ## = NA
Spec Sheet: NovAseptic® Valve - NA##/311-222 and NU###/311-222
Tube Size NA12/311-222 8.8 (0.346) 20.3 (0.799) 34.0 (1.339) 42.0 (1.654) TR40 x 2 25.0 (0.984) 12.0 x 1.0 NU050/311-222 12.7 x 1.65 (0.50 x 0.065) NA18/311-222 11.0 (0.433) 27.5
Spec Sheet: NovAseptic® Valve - NA##/32-222 and NU###/32-222
Catalogue Number: NA##/32-222 and NU###/32-222 D A Tube Tube B CC TC TCTC Tube E Catalogue No. Structure NA##/32-222 NU###/32-222 ## = NA tube
NovAseptic Valve - Valve Body, Divert Valve TC - Catalogue Number NA##/39-212 and NU###/39-212
Catalogue Number: NA##/39-222 and NU###/39-222 D A 1 Tube B C2C1 A 2 Tube A 2 Tube T C T C T C C 3 C4 D A 3 A
NovAseptic Valve: Valve Body, Flow through 180°, TC connectable, Elbow 45° TC
No. Net Volume (valve cavity, diaphragm applied) mL Net Weight (approximate) kg (lb) NU050/4722-222 4 0.3 (0.66) Material Bar Stainless Steel in Compliance with Tubing Stainless Steel in Compliance
NovAseptic Valve: Valve Body, Shut off 90°, TC connectable, Elbow 45° TC
No. Net Volume (valve cavity, diaphragm applied) mL Net Weight (approximate) kg (lb) NU050/4712-222 4 0.3 (0.66) Material Bar Stainless Steel in Compliance with Tubing Stainless Steel in Compliance
Product Information Sheet - A6140
A.6 (and 1.6) (1989). ADDITIONAL REFERENCES: Bundgaard, H., J. Pharm. Pharmac., 26, 385-392 (1974). "Spectrophotometric determination of ampicillin sodium..." Clarke's Isolation and Identification
Product Information Sheet - A9393
A.6 (and 1.6) (1989). ADDITIONAL REFERENCES: Bundgaard, H., J. Pharm. Pharmac., 26, 385-392 (1974). "Spectrophotometric determination of ampicillin sodium..." Clarke's Isolation and Identification
Data Sheet - M7681
dilutions by titration test. References 1. Clifton, A.D., Young, P.R. and Cohen, P., FEBS Lett., 392, 209 (1996). 2. Stokoe, D., Campbell, D.G., Nakielny, S., Hidaka, H., Leevers, S.J., Marshall, C
High-Volume Vacuum or Pressure Pump User Guide
temperature 1°C to 40°C Safety compliance 115 V CSA approved 220 V CE compliant - 89/356/EEC 89/392/EEC 91/368/EEC Ordering Information Description Catalogue Number Vacuum/pressure pump, high volume
XP725 Antibody Number-Lot Number 071M4826
381 382 383 384 5.1 385 386 387 388 409 410 411 412 433 434 435 436 457 458 459 460 5.2 389 390 391 392 413 414 415 416 437 438 439 440 461 462 463 464 5.3 393 394 395 396
Quality Control Range Sheet- 6192-101 and 6192-201
Range Units IP-10 Control 1 322-668 pg/mL sICAM-1 Control 1 4804-9977 pg/mL BAFF Control 1 189-392 pg/mL Control 2 1550-3220 pg/mL Control 2 21227-44086 pg/mL Control 2 823-1710 pg/mL
MultiScreen Deep Well Solvinert Filter Plate: High throughput sample preparation for the quantitation of drug compounds in serum samples
MT552) and Warfarin (MT1620) were purchased from Moravek Biochemicals (Brea, CA) Ibuprofen (ART 392) and Verapamil (ART 667) were purchased from American Radiolabeled Chemicals, Inc. (St. Louis, MO)
High throughput sample preparation for the quantitation of drug compounds in serum samples
MT552) and Warfarin (MT1620) were purchased from Moravek Biochemicals (Brea, CA). Ibuprofen (ART 392) and Verapamil (ART 667) were purchased from American Radiolabeled Chemicals, Inc. (St. Louis, MO)
Protocol- 03-0145-00
Diluent (for triplicates, transfer 8 µL of clarified sample to the sample preparation plate and add 392 µL Standard Diluent. For research use only.
XP725 Antibody List Lot 129K4831
Peroxiredoxin 3 P1247 10935 PRDX3 P NP_006784.1 y n/d n/d 391 JAB 1 J3395 10987 COPS5 P NP_006828.2 y y y 392 JAB 1 J3020 10987 COPS5 P NP_006828.2 y y y 224 Destrin/ADF D8940 11034 DSTN P NP_001011546.1 y y y
XP725 Antibody List Lot 129K4830
Peroxiredoxin 3 P1247 10935 PRDX3 P NP_006784.1 y n/d n/d 391 JAB 1 J3395 10987 COPS5 P NP_006828.2 y y y 392 JAB 1 J3020 10987 COPS5 P NP_006828.2 y y y 224 Destrin/ADF D8940 11034 DSTN P NP_001011546.1 y y y
XP725 Antibody List Lot 089K4791
Peroxiredoxin 3 P1247 10935 PRDX3 P NP_006784.1 y n/d n/d 391 JAB 1 J3395 10987 COPS5 P NP_006828.2 y y y 392 JAB 1 J3020 10987 COPS5 P NP_006828.2 y y y 224 Destrin/ADF D8940 11034 DSTN P NP_001011546.1 y y y
User Guide accu-jet® S - multi language
................................. 221 4 调试 .................................................... 222 4.1 连接电池 ...........................................222 4.2 电池充电 ............................
List of Antibodies
www.sigmaaldrich.com/ProductLookup.html?ProdNo=I0282&Brand=SIGMA� y y y 391 JAB 1 J3395 P y y y 392 JAB 1 J3020 P y y y 393 JAK 1 J3774 M y n/d n/d 394 c-Jun N-Terminal Kinase J4500 P y
XP725 Worksheet for Lot Number 071M4826
2 1 4 1 CaM Kinase IV C9973 218 2 1 4 2 CaM Kinase IV C9973 219 2 1 4 3 CASK LIN2 C4856 220 2 1 4 4 CASK LIN2 C4856 221 2 1 4 5 Casein Kinase 2b C3617 222 2 1
Halal Certificate
, FG W213810 B16051 HC-22SIZB80 391. BENZYL BUTYRATE 98%, FCC, FG W214000 B69641 HC-22SIEK52 392. BENZYL BUTYRATE NATURAL, 98%, FCC W214019 A29284 HC-22SI2K65 393. BENZYL CINNAMATE 98% W214205
Halal Certificate
, FG W213810 B16051 HC-24SI1A82 391. BENZYL BUTYRATE 98%, FCC, FG W214000 B69641 HC-24SISM54 392. BENZYL BUTYRATE NATURAL, 98%, FCC W214019 A29284 HC-24SIAO67 393. BENZYL CINNAMATE 98% W214205
XP725 Antibody List
y 391 JAB 1 J3395 312916, 26754, 10987 COPS5,Cops5 NP_001020866.1,NP_038743.1,NP_006828.2 P y y y 392 JAB 1 J3020 312916, 26754, 10987 COPS5,Cops5 NP_001020866.1,NP_038743.1,NP_006828.2 P y y y 393 JAK
XP725 Antibody List 013M4793
y 391 JAB 1 J3395 312916, 26754, 10987 COPS5,Cops5 NP_001020866.1,NP_038743.1,NP_006828.2 P y y y 392 JAB 1 J3020 312916, 26754, 10987 COPS5,Cops5 NP_001020866.1,NP_038743.1,NP_006828.2 P y y y 393 JAK
Chrombook 2015 - The world of chromatography in your hands
Problem: Varying retention times 391 Peaks Problem: Broad peaks 391-392 Problem: Ghost peaks 392 Problem: Negative peaks 392 Problem: Peak doubling 393 Problem: Peak fronting 393 Problem: Peak
Inhibitor Sourcebook 3rd Edition
Marte, B.M., et al. 1994. Cell Growth Differ. 5, 239. 3. Gschwendt, M., et al. 1996. FEBS Lett. 392, 77. 4. Jirousek, M.R., et al. 1996. J. Med. Chem. 39, 2664. 5. Tanaka, M., et al. 2004. Bioorg. Med.